In vitro receptor occupancy allows to establish equieffective doses of beta-blockers with different pharmacodynamic profiles in man. Investigations with propranolol and bufuralol.

Source:http://linkedlifedata.com/resource/pubmed/id/3007897

Download in:

View as

General Info

PMID
3007897